Precision Therapeutics Signs Letter of Intent to Purchase Remainder of Helomics Corporation Shares Pharmaceutical Investing
Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA Pharmaceutical Investing
Innovation Pharmaceuticals Signs Drug Supply Contract with Evonik to Bulk Produce Commercial-Grade Brilacidin Pharmaceutical Investing
AzurRx BioPharma and Mayoly-Spindler Announce Additional Positive Interim Data for MS1819-SD Phase II Biotech Investing
Abeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease Pharmaceutical Investing
Clementia Initiates Phase 2 MO-Ped Trial for Palovarotene in Patients with Multiple Osteochondromas Pharmaceutical Investing
Xanthic Biopharma Inc. Announces LOI with Licensed Producer, Green Mile Solutions LLC, for Production and Sale of Xanthic-Infused Products in Oregon, Nevada and Ohio Cannabis Investing News
Xanthic Biopharma Inc. Closes First Tranche of Oversubscribed Private Placement Cannabis Investing News
Xanthic Biopharma Inc. to Commence Trading on the Canadian Securities Exchange Cannabis Investing News
